Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL MEDICATED CONFECTIONERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL MEDICATED CONFECTIONERY MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 DEMAND AND SUPPLY-SIDE VARIABLES
2.2.8 CONSUMPTION TREND OF END PRODUCTS
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 STANDARDS OF MEASUREMENT
2.2.11 VENDOR SHARE ANALYSIS
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL MEDICATED CONFECTIONERY MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 VALUE CHAIN ANALYSIS
5.2 SUPPLY CHAIN ANALYSIS
5.3 IMPORT-EXPORT ANALYSIS
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 BARGAINING POWER OF SUPPLIERS
5.4.2 BARGAINING POWER OF BUYERS/CONSUMERS
5.4.3 THREAT OF NEW ENTRANTS
5.4.4 THREAT OF SUBSTITUTE PRODUCTS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 RAW MATERIAL SOURCING ANALYSIS
5.6 OVERVIEW OF TECHNOLOGICAL INNOVATIONS
5.7 INDUSTRY TRENDS AND FUTURE PERSPECTIVE
5.8 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS
5.9 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS
5.1 SHOPPING BEHAVIOUR AND DYNAMICS
5.10.1 RECOMMENDATION FROM FAMILY & FRIENDS
5.10.2 RESEARCH
5.10.3 IMPULSIVE
5.10.4 ADVERTISEMENT
5.11 PROMOTIONAL ACTIVITIES
5.12 CONSUMER DISPOSABLE INCOME DYNAMICS/SPEND DYNAMICS
5.13 NEW PRODUCT LAUNCH STRATEGY
5.13.1 NUMBER OF NEW PRODUCT LAUNCH
5.13.1.1. LLINE EXTENSTION
5.13.1.2. NNEW PACKAGING
5.13.1.3. RRE-LAUNCHED
5.13.1.4. NNEW FORMULATION
5.14 CONSUMER LEVEL TRENDS
5.15 MEETING CONSUMER REQUIREMENT
6 IMPACT OF ECONOMIC SLOW DOWN ON MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON SUPPLY CHAIN
6.3 IMPACT ON SHIPMENT
6.4 IMPACT ON COMPANY’S STRATEGIC DECISIONS
7 REGULATORY FRAMEWORK AND GUIDELINES
8 PRICING ANALYSIS
9 PRODUCTION CAPACITY OF KEY MANUFACTURERES
10 BRAND OUTLOOK
10.1 COMPARATIVE BRAND ANALYSIS
10.2 PRODUCT VS BRAND OVERVIEW
11 GLOBAL MEDICATED CONFECTIONERY MARKET, BY TYPE, 2021-2030 (USD MILLION)
11.1 OVERVIEW
11.2 HARD CANDY
11.3 CHEWING GUMS
11.4 GUMMIES AND JELLIES
11.5 PASTILLES
11.6 CHOCOLATE BARS
11.6.1 CHOCOLATE BARS, BY TYPE
11.6.1.1. MILK CHOCOLATE
11.6.1.2. DARK CHOCOLATE
11.6.1.3. WHITE CHOCOLATE
11.7 CHOCOLATE BITES
11.7.1 CHOCOLATE BITES, BY TYPE
11.7.1.1. MILK CHOCOLATE
11.7.1.2. DARK CHOCOLATE
11.7.1.3. WHITE CHOCOLATE
11.8 OTHERS
12 GLOBAL MEDICATED CONFECTIONERY MARKET, BY NATURE , 2021-2030 (USD MILLION)
12.1 OVERVIEW
12.2 ORGANIC
12.3 CONVENTIONAL
13 GLOBAL MEDICATED CONFECTIONERY MARKET, BY FUNCTION, 2021-2030 (USD MILLION)
13.1 OVERVIEW
13.2 THROAT IRRITATION
13.3 RESPIRATORY CONGESTION
13.4 ALLERGIES
13.5 OTHERS
14 GLOBAL MEDICATED CONFECTIONERY MARKET, BY SWEETNESS CATEGORY , 2021-2030 (USD MILLION)
14.1 OVERVIEW
14.2 REGULAR/ WITH SUGAR
14.3 LOW SUGAR
14.4 SUGAR-FREE
15 GLOBAL MEDICATED CONFECTIONERY MARKET, BY BRANDED CATEGORY , 2021-2030 (USD MILLION)
15.1 OVERVIEW
15.2 BRANDED
15.3 PRIVATE LABEL
16 GLOBAL MEDICATED CONFECTIONERY MARKET, BY PACKAGING TYPE, 2021-2030 (USD MILLION)
16.1 OVERVIEW
16.2 POUCHES
16.3 PLASTIC WRAP
16.4 SACHETS
16.5 BOX
16.6 OTHERS
17 GLOBAL MEDICATED CONFECTIONERY MARKET, BY END USE, 2021-2030 (USD MILLION)
17.1 OVERVIEW
17.2 ADULTS
17.3 KIDS
18 GLOBAL MEDICATED CONFECTIONERY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
18.1 OVERVIEW
18.2 STORE-BASED RETAILING
18.2.1 STORE-BASED RETAILING, BY TYPE
18.2.1.1. SUPERMARKETS / HYPERMARKETS
18.2.1.2. GROCERY STORES
18.2.1.3. CONVENIENCE STORES
18.2.1.4. SPECIALTY STORES
18.2.1.5. PHARMACIES / DRUG STORES
18.2.1.6. WHOLESALERS
18.2.1.7. OTHERS
18.3 NON-STORE RETAILING
18.3.1 NON-STORE RETAILING, BY TYPE
18.3.1.1. E-COMMERCE RETAILER
18.3.1.2. COMPANY WEBSITES
18.3.1.3. VENDING MACHINES
19 GLOBAL MEDICATED CONFECTIONERY MARKET, BY GEOGRAPHY, 2021-2030 (USD MILLION)
GLOBAL MEDICATED CONFECTIONERY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
19.1 NORTH AMERICA
19.1.1 U.S.
19.1.2 CANADA
19.1.3 MEXICO
19.2 EUROPE
19.2.1 GERMANY
19.2.2 U.K.
19.2.3 ITALY
19.2.4 FRANCE
19.2.5 SPAIN
19.2.6 SWITZERLAND
19.2.7 RUSSIA
19.2.8 TURKEY
19.2.9 BELGIUM
19.2.10 NETHERLANDS
19.2.11 SWITZERLAND
19.2.12 DENMARK
19.2.13 NORWAY
19.2.14 FINLAND
19.2.15 SWEDEN
19.2.16 REST OF EUROPE
19.3 ASIA-PACIFIC
19.3.1 JAPAN
19.3.2 CHINA
19.3.3 SOUTH KOREA
19.3.4 INDIA
19.3.5 SINGAPORE
19.3.6 THAILAND
19.3.7 INDONESIA
19.3.8 MALAYSIA
19.3.9 PHILIPPINES
19.3.10 AUSTRALIA
19.3.11 NEW ZEALAND
19.3.12 HONG KONG
19.3.13 TAIWAN
19.3.14 REST OF ASIA-PACIFIC
19.4 SOUTH AMERICA
19.4.1 BRAZIL
19.4.2 ARGENTINA
19.4.3 REST OF SOUTH AMERICA
19.5 MIDDLE EAST AND AFRICA
19.5.1 SOUTH AFRICA
19.5.2 EGYPT
19.5.3 SAUDI ARABIA
19.5.4 UNITED ARAB EMIRATES
19.5.5 ISRAEL
19.5.6 BAHRAIN
19.5.7 KUWAIT
19.5.8 OMAN
19.5.9 QATAR
19.5.10 REST OF MIDDLE EAST AND AFRICA
20 GLOBAL MEDICATED CONFECTIONERY MARKET, COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: US
20.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
20.3 COMPANY SHARE ANALYSIS: EUROPE
20.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
20.5 MERGERS & ACQUISITIONS
20.6 NEW PRODUCT DEVELOPMENT & APPROVALS
20.7 EXPANSIONS
20.8 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
21 GLOBAL MEDICATED CONFECTIONERY MARKET, COMPANY PROFILE
21.1 A.L.SIMPKIN & CO. LTD
21.1.1 COMPANY OVERVIEW
21.1.2 REVENUE ANALYSIS
21.1.3 GEOGRAPHICAL PRESENCE
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENTS
21.2 PER OS BIOSCIENCES LLC
21.2.1 COMPANY OVERVIEW
21.2.2 REVENUE ANALYSIS
21.2.3 GEOGRAPHICAL PRESENCE
21.2.4 PRODUCT PORTFOLIO
21.2.5 RECENT DEVELOPMENTS
21.3 MONDELEZ INTERNATIONAL
21.3.1 COMPANY OVERVIEW
21.3.2 REVENUE ANALYSIS
21.3.3 GEOGRAPHICAL PRESENCE
21.3.4 PRODUCT PORTFOLIO
21.3.5 RECENT DEVELOPMENTS
21.4 RICOLA
21.4.1 COMPANY OVERVIEW
21.4.2 REVENUE ANALYSIS
21.4.3 GEOGRAPHICAL PRESENCE
21.4.4 PRODUCT PORTFOLIO
21.4.5 RECENT DEVELOPMENTS
21.5 PERFETTI VAN MELLE
21.5.1 COMPANY OVERVIEW
21.5.2 REVENUE ANALYSIS
21.5.3 GEOGRAPHICAL PRESENCE
21.5.4 PRODUCT PORTFOLIO
21.5.5 RECENT DEVELOPMENTS
21.6 ENORAMA PHARMA AB
21.6.1 COMPANY OVERVIEW
21.6.2 REVENUE ANALYSIS
21.6.3 GEOGRAPHICAL PRESENCE
21.6.4 PRODUCT PORTFOLIO
21.6.5 RECENT DEVELOPMENTS
21.7 GELSTAT CORPORATION
21.7.1 COMPANY OVERVIEW
21.7.2 REVENUE ANALYSIS
21.7.3 GEOGRAPHICAL PRESENCE
21.7.4 PRODUCT PORTFOLIO
21.7.5 RECENT DEVELOPMENTS
21.8 MARS, INCORPORATED
21.8.1 COMPANY OVERVIEW
21.8.2 REVENUE ANALYSIS
21.8.3 GEOGRAPHICAL PRESENCE
21.8.4 PRODUCT PORTFOLIO
21.8.5 RECENT DEVELOPMENTS
21.9 SAMBUCOL USA
21.9.1 COMPANY OVERVIEW
21.9.2 REVENUE ANALYSIS
21.9.3 GEOGRAPHICAL PRESENCE
21.9.4 PRODUCT PORTFOLIO
21.9.5 RECENT DEVELOPMENTS
21.1 BIOVANTA
21.10.1 COMPANY OVERVIEW
21.10.2 REVENUE ANALYSIS
21.10.3 GEOGRAPHICAL PRESENCE
21.10.4 PRODUCT PORTFOLIO
21.10.5 RECENT DEVELOPMENTS
21.11 FISHERMANSFRIEND
21.11.1 COMPANY OVERVIEW
21.11.2 REVENUE ANALYSIS
21.11.3 GEOGRAPHICAL PRESENCE
21.11.4 PRODUCT PORTFOLIO
21.11.5 RECENT DEVELOPMENTS
21.12 LOZEN PHARMA
21.12.1 COMPANY OVERVIEW
21.12.2 REVENUE ANALYSIS
21.12.3 GEOGRAPHICAL PRESENCE
21.12.4 PRODUCT PORTFOLIO
21.12.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
22 RELATED REPORTS
23 QUESTIONNAIRE
24 ABOUT DATA BRIDGE MARKET RESEARCH
